Haun G, Keppler O T, Bock C T, Herrmann M, Zentgraf H, Pawlita M
Angewandte Tumorvirologie, Deutsches Krebsforschungszentrum, Heidelberg, Germany.
J Virol. 1993 Dec;67(12):7482-92. doi: 10.1128/JVI.67.12.7482-7492.1993.
The B-lymphotropic papovavirus (LPV) productively infects only a subset of human B-lymphoma-derived cell lines while transfection of the viral genome yields infectious viral particles in a much wider variety of human hematopoietic cell lines. We have analyzed the contribution of a putative LPV receptor on the cell surface of B-cell lines in restricting the virus host range. In order to establish a quantitative virus binding assay for LPV, infectious virus particles were highly purified by metrizamide equilibrium density centrifugation and used as immunogens to raise seven mouse monoclonal antibodies specific for LPV VP1. Virus particle binding was quantitated in an indirect, nonradioactive assay with an LPV VP1-specific enzyme-linked immunosorbent assay. Binding of LPV particles to permissive human B-lymphoma cell line BJA-B occurred within minutes. Kinetics and capacity of binding were similar at 4 and 37 degrees C. A BJA-B cell was estimated to bind approximately 600 virus particles at conditions under which 50% of the administered virus was bound. The sialidase and trypsin sensitivities of the cellular virus binding moiety show that sialylated and proteinaceous components are necessary components of the LPV receptor on BJA-B cells. Despite a high binding capacity of BJA-B cells for simian virus 40, LPV binding was not significantly affected by a 20-fold excess of simian virus 40 particles, indicating that these related polyomaviruses do not bind to the same receptor on BJA-B cells. Reduction of LPV binding to sialidase-pretreated BJA-B cells was accompanied by a similar reduction of infection, indicating that virus binding may be a limiting factor in the LPV replicative cycle. The two highly LPV-permissive human B-lymphoma cell lines BJA-B and Namalwa displayed high virus binding whereas low and nonpermissive hematopoietic cell lines showed reduced or undetectable virus binding. We conclude that the inability of LPV particles to productively infect the nonpermissive human hematopoietic cell lines analyzed is probably due to the absence or insufficient expression of a functional cell surface receptor.
嗜B淋巴细胞乳头瘤病毒(LPV)仅能有效感染一部分源自人B淋巴瘤的细胞系,而病毒基因组的转染能在更多种类的人造血细胞系中产生有感染性的病毒颗粒。我们分析了B细胞系细胞表面一种假定的LPV受体在限制病毒宿主范围方面的作用。为建立LPV的定量病毒结合测定法,通过氯化铯平衡密度离心法高度纯化有感染性的病毒颗粒,并将其用作免疫原以产生7种针对LPV VP1的小鼠单克隆抗体。用LPV VP1特异性酶联免疫吸附测定法在间接非放射性测定中对病毒颗粒结合进行定量。LPV颗粒与允许性人B淋巴瘤细胞系BJA - B的结合在数分钟内即可发生。在4℃和37℃时,结合的动力学和能力相似。据估计,在50%的施用病毒被结合的条件下,一个BJA - B细胞可结合约600个病毒颗粒。细胞病毒结合部分对唾液酸酶和胰蛋白酶的敏感性表明,唾液酸化和蛋白质成分是BJA - B细胞上LPV受体的必要组成部分。尽管BJA - B细胞对猴病毒40有高结合能力,但20倍过量的猴病毒40颗粒对LPV结合没有显著影响,这表明这些相关的多瘤病毒不会结合到BJA - B细胞上的同一受体。LPV与经唾液酸酶预处理的BJA - B细胞结合的减少伴随着感染的类似减少,这表明病毒结合可能是LPV复制周期中的一个限制因素。两种对LPV高度允许的人B淋巴瘤细胞系BJA - B和Namalwa显示出高病毒结合,而低允许性和非允许性造血细胞系则显示出病毒结合减少或无法检测到。我们得出结论,LPV颗粒无法有效感染所分析的非允许性人造血细胞系,可能是由于功能性细胞表面受体的缺失或表达不足。